Stay updated on Nivolumab in Refractory Biliary Tract Cancers Clinical Trial

Sign up to get notified when there's something new on the Nivolumab in Refractory Biliary Tract Cancers Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab in Refractory Biliary Tract Cancers Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The website has been updated from version 2.14.1 to 2.14.2.
    Difference
    0.1%
    Check dated 2025-02-03T05:30:44.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    The website has been updated from version 2.14.0 to 2.14.1.
    Difference
    0.1%
    Check dated 2025-01-19T20:08:40.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The website has updated the 'type of intervention' feature from version 2.13.3 to 2.14.0, indicating a significant change in this functionality.
    Difference
    0.2%
    Check dated 2025-01-12T17:03:30.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    The website has been updated from version 2.13.2 to 2.13.3.
    Difference
    0.1%
    Check dated 2024-12-14T12:16:51.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    The website has updated the contact details section for the study, replacing the previous information with new details about who to contact and where the study is taking place, along with a revision update from v2.12.2 to v2.13.2.
    Difference
    3%
    Check dated 2024-12-07T10:14:56.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    Recent updates include new entries for November 2024, while previous updates from July 2024 have been removed.
    Difference
    0.6%
    Check dated 2024-11-30T08:31:08.000Z thumbnail image

Stay in the know with updates to Nivolumab in Refractory Biliary Tract Cancers Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab in Refractory Biliary Tract Cancers Clinical Trial page.